As of 2025-10-27, the Intrinsic Value of Athira Pharma Inc (ATHA) is -75.96 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.07 USD, the upside of Athira Pharma Inc is -1,966.23%.
Based on its market price of 4.07 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 1,966.23%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -75.96 - -75.96 | -75.96 | -1,966.23% |
| DDM - Stable | (133.00) - (417.50) | (275.25) | -6862.9% |
| DDM - Multi | (197.70) - (487.86) | (281.99) | -7028.6% |
| Market Cap (mil) | 16.04 |
| Beta | 1.80 |
| Outstanding shares (mil) | 3.94 |
| Enterprise Value (mil) | 16.04 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.63% |
| Cost of Debt | 5.00% |
| WACC | 6.65% |